Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

April 29, 2014 20:36 ET

Cease Trade Order Revoked Premier Diagnostic Health Services Inc.

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 29, 2014) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostic Health Services Inc. ("PDHS" or the "Company") (CSE:PDH) announces that on April 28, 2014 the Ontario Securities Commission ("OSC") issued a full revocation order with respect to the cease trade order dated February 27, 2014 issued by the OSC. The revocation order was issued following the Company's completion and filing of audited annual financial statements for the year ended September 30, 2013 and the related management's discussion and analysis and certification of the foregoing filings as required by National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings ("NI 52-109"), and completion and filing of management-prepared interim financial statements for the period ended December 31, 2013 and the related management's discussion and analysis and certification of the foregoing filings as required by NI 52-109.

The delay in filing the continuous disclosure documents referenced above was caused by delays in the provision of certain financial information by the Company's Chinese subsidiary.

The cease trade order dated February 6, 2014 of the British Columbia Securities Commission was revoked on April 23, 2014.

About Premier Diagnostic Health Services Inc. ("PDHS")

PDHS is a Canadian company that provides advanced medical diagnostic tools utilizing PET/CT technology and/or MRI technology and related diagnostic skills in Canada and in partnership with hospitals and clinics in the People's Republic of China. The Company's vision is to provide services that support improving medical decisions around the world. The Company's approach involves building long-term relationships regarding management, quality, and financial services that are necessary to build, operate and grow the diagnostic capacity and capability of hospitals and clinics.

On behalf of the Board of Directors

Denis Tusar, President and CEO

The Canadian Stock Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at www.sedar.com.

Contact Information